Analyst Reco. Amgen Inc.

Equities

AMGN

US0311621009

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:00:00 2025-01-23 pm EST			5-day change	1st Jan Change
277.88 ^USD	+1.62%		+3.14%	+6.61%

Jan. 17	Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks	MT
Jan. 17	Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks	MT

Analyst Reco.

Wells Fargo Cuts Price Target on Amgen to $280 From $335, Maintains Equalweight Rating	Jan. 10	MT
Goldman Sachs Adjusts Price Target on Amgen to $370 From $375, Maintains Buy Rating	Jan. 08	MT
Truist Lowers Price Target on Amgen to $298 From $333, Keeps Hold Rating	Jan. 08	MT
RBC Trims Price Target on Amgen to $324 From $330, Keeps Outperform Rating	Jan. 07	MT
Jefferies Adjusts Amgen Price Target to $350 From $380, Maintains Buy Rating	Dec. 19	MT
UBS Cuts Price Target on Amgen to $280 From $326, Maintains Neutral Rating	Dec. 17	MT
Deutsche Bank Lowers Amgen Price Target to $285 From $305, Maintains Hold Rating	Dec. 02	MT
Leerink Partners Adjusts Price Target on Amgen to $305 From $352, Maintains Market Perform Rating	Nov. 27	MT
Redburn Atlantic Adjusts Price Target on Amgen to $195 From $200, Maintains Sell Rating	Nov. 27	MT
Deutsche Bank Adjusts Price Target on Amgen to $285 From $305, Maintains Hold Rating	Nov. 27	MT
RBC Adjusts Price Target on Amgen to $330 From $360, Maintains Outperform Rating	Nov. 27	MT
Citigroup Adjusts Price Target on Amgen to $310 From $335, Neutral Rating Maintained	Nov. 26	MT
RBC Cuts Price Target on Amgen to $360 From $362, Maintains Outperform Rating	Nov. 25	MT
HSBC Adjusts Price Target on Amgen to $385 From $369	Nov. 13	MT
UBS Adjusts Price Target on Amgen to $326 From $335, Maintains Neutral Rating	24-10-31	MT
Goldman Sachs Adjusts Price Target on Amgen to $375 From $369, Maintains Buy Rating	24-10-31	MT
Morgan Stanley Raises Price Target on Amgen to $322 From $319, Keeps Equalweight Rating	24-10-31	MT
TD Cowen Adjusts Price Target on Amgen to $383 From $381	24-10-21	MT
TD Cowen Adjusts Amgen Price Target to $383 From $381	24-10-21	MT
Truist Downgrades Amgen to Hold From Buy, Raises Price Target to $333 From $320	24-10-14	MT
Morgan Stanley Adjusts Price Target on Amgen to $319 From $316	24-10-11	MT
JPMorgan Adjusts Price Target on Amgen to $300 From $290, Maintains Neutral Rating	24-10-09	MT
Goldman Sachs Adjusts Price Target on Amgen to $369 From $370	24-10-04	MT
Barclays Adjusts Price Target on Amgen to $315 From $300, Maintains Equalweight Rating	24-10-04	MT
Redburn Atlantic Adjusts Amgen Price Target to $200 From $180, Maintains Sell Rating	24-09-19	MT

Become a member to access more news.

100% Free Registration

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Amgen Inc.

Equities

AMGN

US0311621009

Pharmaceuticals

Analyst Reco.

Filters